title: Plasma C-reactive protein in subjects with hypo/hyperalphalipoproteinemias.
abstract: Hypoalphalipoproteinemia (Hypo-A), a lipid disorder characterized by low high-density lipoprotein (HDL)-cholesterol (HDL-C) levels, is frequently associated with an increased risk of suffering future coronary heart disease (CHD). Conversely, hyperalphalipoproteinemia (Hyper-A) is a characterized by high HDL-C concentrations and is possibly associated with longevity and protection against CHD. Whether plasma C-reactive protein (CRP) level, an emerging marker of CHD risk, may be influenced by either extremely low or high HDL-C concentrations is yet to be determined. Plasma levels of lipids and CRP have been measured in 52 middle-aged men and women, clinically free of CHD, including 20 subjects with Hypo-A, 12 with Hyper-A, and 20 healthy normolipemic age-matched controls. CRP levels were the highest in Hypo-A [0.22 mg/dL (interquartile range, 0.15 to 0.44)], the lowest in Hyper-A [0.03 mg/dL (0.02 to 0.07)], and intermediate in the control group [0.10 mg/dL (0.05 to 0.20)]. Differences in plasma CRP concentrations were significant between Hypo-A and the other 2 groups, as well as between Hyper-A and controls. Plasma CRP levels showed a particularly strong correlation with plasma HDL-C concentrations (r = -.66, P <.001). In multivariate models, HDL-C represented the only significant predictor of circulating levels of CRP. In conclusion, in subjects with Hypo-A or Hyper-A, HDL-C levels may account for plasma CRP variations independent of other potential cardiovascular risk factors.
authors.affiliation: Internal Medicine, Angiology and Arteriosclerosis Diseases, Department of Clinical and Experimental Medicine, University of Perugia, Italy.
authors.forename: Matteo
authors.initials: M
authors.lastname: Pirro
authors.forename: Donatella
authors.initials: D
authors.lastname: Siepi
authors.forename: Graziana
authors.initials: G
authors.lastname: Lupattelli
authors.forename: Anna Rita
authors.initials: AR
authors.lastname: Roscini
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Schillaci
authors.forename: Fabio
authors.initials: F
authors.lastname: Gemelli
authors.forename: Gaetano
authors.initials: G
authors.lastname: Vaudo
authors.forename: Simona
authors.initials: S
authors.lastname: Marchesi
authors.forename: Leonella
authors.initials: L
authors.lastname: Pasqualini
authors.forename: Elmo
authors.initials: E
authors.lastname: Mannarino
mesh_terms: D000328:Adult; D015992:Body Mass Index; D002097:C-Reactive Protein / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000097:blood / Q000235:genetics; D008076:Cholesterol, HDL / Q000097:blood; D015331:Cohort Studies; D005260:Female; D006801:Humans; D006951:Hyperlipoproteinemias / Q000097:blood*; D007009:Hypolipoproteinemias / Q000097:blood*; D008075:Lipoproteins, HDL / Q000097:blood*; D008297:Male; D008875:Middle Aged; D012307:Risk Factors
chemical_list: D008076:Cholesterol, HDL; D008075:Lipoproteins, HDL; D002097:C-Reactive Protein